1. Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI)

   • Wolfgang von Scheidt
   • A. Welz
   • H. M. Hoffmeister

   Critical Perspective 13 August 2019 Pages: 1 - 12

   

2. Obstructive sleep apnea is associated with pulmonary artery thrombus load, disease severity, and survival in acute pulmonary embolism

   • Fabian Geissenberger
   • Florian Schwarz
   • Thomas M. Berghaus

   Original Paper 23 April 2019 Pages: 13 - 21

   

3. Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case–control analyses

   • João Pedro Ferreira
   • Anne Pizard
   • the FIBRO-TARGETS investigators

   Original Paper 06 May 2019 Pages: 22 - 33

   

4. Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation: results of the PAPRICA-3 study

   • Òscar Miró
   • Koji Takagi
   • Alexandre Mebazaa

   Original Paper 29 April 2019 Pages: 34 - 45

   

5. Real-world clinical experience with the percutaneous extracorporeal life support system: Results from the German Lifebridge^® Registry

   • Maryna Masyuk
   • Peter Abel
   • Christian Jung

   Original Paper 26 April 2019 Pages: 46 - 53

   

6. Right atrial–right ventricular coupling in heart failure with preserved ejection fraction

   • Maximilian von Roeder
   • Johannes Tammo Kowallick
   • Philipp Lurz

   Original Paper 03 May 2019 Pages: 54 - 66

   

7. Temporal trends in management and outcome of pulmonary embolism: a single-centre experience

   • Matthias Ebner
   • Karl-Patrik Kresoja
   • Mareike Lankeit

   Original Paper Open access 07 May 2019 Pages: 67 - 77

   

8. When and how do patients with cardiac amyloidosis die?

   • F. Escher
   • M. Senoner
   • G. Poelzl

   Original Paper Open access 27 May 2019 Pages: 78 - 88

   

9. Prognostic relevance of new onset arrhythmia and ICD shocks in primary prophylactic ICD patients

   • Thomas Kleemann
   • Margit Strauss
   • Ralf Zahn

   Original Paper 13 May 2019 Pages: 89 - 95

   

10. Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices

    • Daniele Pastori
    • Kazuo Miyazawa
    • Gregory Y. H. Lip

    Original Paper 29 May 2019 Pages: 96 - 102

    

11. Area-based socioeconomic status and mortality: the Ludwigshafen Risk and Cardiovascular Health study

    • Angela P. Moissl
    • Graciela E. Delgado
    • Tanja B. Grammer

    Original Paper 29 May 2019 Pages: 103 - 114

    

12. Cardioverter–defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction

    • Clemens Jilek
    • Thorsten Lewalter
    • Jochen Senges

    Original Paper 24 June 2019 Pages: 115 - 123

    

13. Sex differences in optimal atrioventricular delay in patients receiving cardiac resynchronization therapy

    • Mariëlle Kloosterman
    • Alexander H. Maass

    Letter to the Editors 21 May 2019 Pages: 124 - 127

    

14. Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?

    • Bernhard Wernly
    • Michael Lichtenauer
    • Christian Jung

    Letter to the Editors 29 May 2019 Pages: 128 - 130

    

15. Correction to: Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?

    • Bernhard Wernly
    • Michael Lichtenauer
    • Christian Jung

    Correction 05 July 2019 Pages: 131 - 131

16. Simultaneous inferior and anterior infarction or severe right ventricular involvement?

    • Karl Fengler
    • R. Palitzsch
    • H. Thiele

    Letter to the Editors 11 June 2019 Pages: 132 - 135